Imidazole-Based pH-Sensitive Convertible Liposomes for Anticancer Drug Delivery
In efforts to enhance the activity of liposomal drugs against solid tumors, three novel lipids that carry imidazole-based headgroups of incremental basicity were prepared and incorporated into the membrane of PEGylated liposomes containing doxorubicin (DOX) to render pH-sensitive convertible liposom...
Main Authors: | Ruiqi Huang, Vijay Gyanani, Shen Zhao, Yifan Lu, Xin Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/3/306 |
Similar Items
-
Temoporfin-in-Cyclodextrin-in-Liposome—A New Approach for Anticancer Drug Delivery: The Optimization of Composition
by: Ilya Yakavets, et al.
Published: (2018-10-01) -
Liposomal Drug Delivery Systems and Anticancer Drugs
by: Temidayo O. B. Olusanya, et al.
Published: (2018-04-01) -
Designing Aptamer-Gold Nanoparticle-Loaded pH-Sensitive Liposomes Encapsulate Morin for Treating Cancer
by: Xiaoyuan Ding, et al.
Published: (2020-03-01) -
A decade's worth of impact: Dox loaded liposomes in anticancer activity
by: Puja Ghosh, et al.
Published: (2022-12-01) -
Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
by: Kenan Aloss, et al.
Published: (2023-03-01)